URGENT: This Altcoin Opportunity Won’t Wait – Act Now

It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.

Mark Munch Biography and Net Worth

VP of Bruker

Dr. Munch has served since September 2012 as President, Bruker Nano Group, with responsibility for management of its global operations. He has also served, since July 2015, as an Executive Vice President of Bruker, and in that capacity is responsible for providing oversight to our global information technology function and enterprise resource planning, as well as other strategic management development and business process initiatives. Dr. Munch has also served as President of Bruker Nano, Inc., a wholly owned subsidiary of Bruker, since October 2010. In March 2021, Dr. Munch took on an additional role of Chief Executive Officer of Acuity Spatial Genomics, a Bruker majority investment. Prior to joining Bruker Nano, Inc., from February 2008 to October 2010, Dr. Munch was Executive Vice President of Veeco Instruments Inc. Dr. Munch also served as a Senior Vice President of Coherent, Inc. from February 2006 to January 2008 and as President and Chief Executive Officer of Cooligy, Inc., a subsidiary of Emerson Electric, from 2004 to 2006. Dr. Munch’s background includes over 29 years of experience in marketing, product development, operations and sales, as well as experience in managing significant business units of multi-national corporations. Dr. Munch holds a Bachelor of Science degree in Chemical Engineering from the University of Colorado and a Master of Science degree and a Ph.D. in Chemical Engineering from Stanford University.

What is Mark Munch's net worth?: The estimated net worth of Mark Munch is at least $5.31 million as of September 16th, 2019. Dr. Munch owns 96,063 shares of Bruker stock worth more than $5,311,323 as of December 20th. This net worth approximation does not reflect any other investments that Dr. Munch may own. Additionally, Dr. Munch receives an annual salary of $1,630,000.00 as VP at Bruker. Learn More about Mark Munch's net worth.
How old is Mark Munch?: Dr. Munch is currently 62 years old. There are 6 older executives and no younger executives at Bruker. The oldest executive at Bruker is Mr. Juergen Srega, President of Bruker CALID Group & Bruker Daltonics Division, who is 69 years old. Learn More on Mark Munch's age.
What is Mark Munch's salary?: As the VP of Bruker Co., Dr. Munch earns $1,630,000.00 per year. The highest earning executive at Bruker is Dr. Frank H. Laukien Ph.D., Chairman, CEO & President, who commands a salary of $2,530,000.00 per year. Learn More on Mark Munch's salary.
How do I contact Mark Munch?: The corporate mailing address for Dr. Munch and other Bruker executives is 40 Manning Road, Billerica MA, 01821. Bruker can also be reached via phone at (978) 663-3660 and via email at [email protected]. Learn More on Mark Munch's contact information.
Has Mark Munch been buying or selling shares of Bruker?: Mark Munch has not been actively trading shares of Bruker within the last three months. Most recently, Mark Munch sold 21,210 shares of the business's stock in a transaction on Wednesday, December 15th. The shares were sold at an average price of $79.47, for a transaction totalling $1,685,558.70. Learn More on Mark Munch's trading history.
Who are Bruker's active insiders?: Bruker's insider roster includes Cynthia Friend (Director), Gerald Herman (CFO), Marc Kastner (Director), Frank Laukien (CEO), Mark Munch (VP), Richard Packer (Director), and Hermann Requardt (Director). Learn More on Bruker's active insiders.
Are insiders buying or selling shares of Bruker?: In the last year, Bruker insiders bought shares 1 times. They purchased a total of 100,000 shares worth more than $5,014,000.00. In the last year, insiders at the medical research company sold shares 1 times. They sold a total of 15,000 shares worth more than $1,350,900.00. The most recent insider tranaction occured on November, 18th when CEO Frank H Laukien bought 100,000 shares worth more than $5,014,000.00. Insiders at Bruker own 28.3% of the company. Learn More about insider trades at Bruker.
Information on this page was last updated on 11/18/2024.

Mark Munch Insider Trading History at Bruker

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/15/2021	Sell	21,210	$79.47	$1,685,558.70
9/16/2019	Sell	47,203	$42.87	$2,023,592.61	96,063
9/13/2017	Sell	21,061	$29.97	$631,198.17	60,524
6/8/2017	Sell	73,724	$27.62	$2,036,256.88	106,602

Mark Munch Buying and Selling Activity at Bruker

Bruker Company Overview

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Today's Range

Now: $55.29

$54.62

$56.71

50 Day Range

MA: $58.16

$48.25

$64.54

2 Week Range

Now: $55.29

$48.07

$94.86

Volume

2,548,354 shs

Average Volume

1,124,468 shs

Market Capitalization

$8.38 billion

P/E Ratio

26.58

Dividend Yield

0.34%

Beta

1.18

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.

>> Register for the Workshop Now

Mark Munch Biography and Net Worth

What is Mark Munch's net worth?

How old is Mark Munch?

What is Mark Munch's salary?

How do I contact Mark Munch?

Has Mark Munch been buying or selling shares of Bruker?

Who are Bruker's active insiders?

Are insiders buying or selling shares of Bruker?